Top Midday Gainers

MT Newswires Live12-13

Trevi Therapeutics (TRVI) said Thursday that enrollment in its phase 2b study of investigational therapy Haduvio in idiopathic pulmonary fibrosis with chronic cough has reached 75% of the targeted sample size of 160 patients.

Shares surged more than 74% as intraday trading volume soared to roughly 57.4 million from a daily average of over 526,000.

ServiceTitan (TTAN) stock was up nearly 43% after opening at $101 per share in its Nasdaq debut, higher than the $71-per-share initial public offering price.

Over 2.94 million shares of the company traded intraday.

Liquidity Services (LQDT) shares surged about 34% amid heavy trading after the company reported Thursday a year-over-year increase in Q4 adjusted earnings and sales.

Almost 956,000 shares traded intraday compared with a daily average of about 117,000.

Price: 4.33, Change: +1.84, Percent Change: +73.86

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2491358210?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-13 02:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2491358210","market":"us","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> Trevi <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (TRVI) said Thursday that enrollment in its phase 2b study of investigational therapy Haduvio in idiopathic pulmonary fibrosis with chronic cough has reached 75% of the targeted sample size of 160 patients.</p><p>Shares surged more than 74% as intraday trading volume soared to roughly 57.4 million from a daily average of over 526,000.</p><p><a href=\"https://laohu8.com/S/TTAN\">ServiceTitan</a> (TTAN) stock was up nearly 43% after opening at $101 per share in its Nasdaq debut, higher than the $71-per-share initial public offering price.</p><p>Over 2.94 million shares of the company traded intraday.</p><p><a href=\"https://laohu8.com/S/LQDT\">Liquidity Services</a> (LQDT) shares surged about 34% amid heavy trading after the company reported Thursday a year-over-year increase in Q4 adjusted earnings and sales.</p><p>Almost 956,000 shares traded intraday compared with a daily average of about 117,000.</p><p>Price: 4.33, Change: +1.84, Percent Change: +73.86</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-13 02:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Trevi Therapeutics (TRVI) said Thursday that enrollment in its phase 2b study of investigational therapy Haduvio in idiopathic pulmonary fibrosis with chronic cough has reached 75% of the targeted ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4137","symbol_name":"综合支持服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2491358210","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491358210","pubTimestamp":1734029146,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Trevi Therapeutics  said Thursday that enrollment in its phase 2b study of investigational therapy Haduvio in idiopathic pulmonary fibrosis with chronic cough has reached 75% of the targeted sample size of 160 patients.Shares surged more than 74% as intraday trading volume soared to roughly 57.4 million from a daily average of over 526,000.ServiceTitan  stock was up nearly 43% after opening at $101 per share in its Nasdaq debut, higher than the $71-per-share initial public offering price.Over 2.94 million shares of the company traded intraday.Liquidity Services  shares surged about 34% amid heavy trading after the company reported Thursday a year-over-year increase in Q4 adjusted earnings and sales.Almost 956,000 shares traded intraday compared with a daily average of about 117,000.Price: 4.33, Change: +1.84, Percent Change: +73.86","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4137":"综合支持服务","TTAN":"ServiceTitan","BK4007":"制药","TRVI":"Trevi Therapeutics Inc.","LQDT":"Liquidity Services","BK4122":"互联网与直销零售"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LQDT":0.9,"TRVI":0.9,"TTAN":0.9},"content_text":"Trevi Therapeutics (TRVI) said Thursday that enrollment in its phase 2b study of investigational therapy Haduvio in idiopathic pulmonary fibrosis with chronic cough has reached 75% of the targeted sample size of 160 patients.Shares surged more than 74% as intraday trading volume soared to roughly 57.4 million from a daily average of over 526,000.ServiceTitan (TTAN) stock was up nearly 43% after opening at $101 per share in its Nasdaq debut, higher than the $71-per-share initial public offering price.Over 2.94 million shares of the company traded intraday.Liquidity Services (LQDT) shares surged about 34% amid heavy trading after the company reported Thursday a year-over-year increase in Q4 adjusted earnings and sales.Almost 956,000 shares traded intraday compared with a daily average of about 117,000.Price: 4.33, Change: +1.84, Percent Change: +73.86","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491358210"}